Jan 27, 2025 | Federal Trade Commission (FTC), MedBen Rx, News, Pharmacy Benefits Manager (PBM), Rx Costs, Specialty Drugs, Spread Pricing
Through specialty generic drug markups, three major pharmacy benefit managers (PBMs) earned a collective $7.3 billion above estimated acquisition costs over a five-year period, according to an interim report released by the Federal Trade Commission (FTC)....
Dec 30, 2024 | Cost Savings, Direct-to-Employer Contracting, Formularies, Health care costs, Networks, Pharmacy Benefits Manager (PBM), Research
A recent “Pulse of the Purchaser” survey offers interesting insights about strategies employers are using to successfully lower their medical and pharmacy costs… strategies that, not surprisingly, have long been in use by many MedBen clients. Among...
Oct 28, 2024 | Federal Trade Commission (FTC), Pharmacy, Pharmacy Benefits Manager (PBM), Rebates, Spread Pricing
KFF Health News reports on the disparity between pharmacy benefit manager (PBM) payments to large pharmacy chains compared to small drugstores: “[An American Pharmacy Cooperative] analysis early this year showed chains were paid well beyond the family business...
Jul 23, 2024 | Federal Trade Commission (FTC), Formularies, News, Pharmacy Benefits Manager (PBM)
In an interim report released on July 9, the Federal Trade Commission charges major pharmacy benefit managers of engaging in business practices designed to benefit their own bottom lines at the expense of clients. The FTC report, subtitled “The Powerful...
Apr 1, 2024 | Benefits preservation, Comparative Effectiveness, Cost Savings, Drug costs, MedBen Rx, Pharmacy, Pharmacy Benefits Manager (PBM), Rx Costs, Savings, Specialty Drugs, Transparency
Employers are turning away from the “big three” pharmacy benefits managers to other PBMs that offer greater transparency and lower costs, says Wharton professor of health care management Lawton Robert Burns. As one of those alternatives, MedBen Rx is...
Feb 19, 2024 | Drug costs, Drugmakers, Generic Drugs, Lawsuits, Pharmacy Benefits Manager (PBM)
Leading drug manufacturer Johnson & Johnson is being sued for mismanagement of the company’s pharmacy plan. The lawsuit, which also names J&J’s pharmacy benefits manager (PBM) as a defendant, accuses the company of massively overpaying the PBM for...
